Germline RAD51B variants confer susceptibility to breast and ovarian cancers deficient in homologous recombination.

Tumors harboring biallelic inactivation of RAD51B displayed a small numerical increase in the number of deletions, deletion lengths, and microhomology scores, although this did not reach statistical significance (Fig. 2 ).

also in 111,027 other papers